e-learning
resources
Milan 2017
Wednesday, 13.09.2017
Gene signatures in bronchial diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - The “one airway, one disease” concept at the light of Th2 inflammation
L. Giovannini-Chami (Nice, France)
Source:
International Congress 2017 – Gene signatures in bronchial diseases
Session:
Gene signatures in bronchial diseases
Session type:
Poster Discussion
Number:
4938
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Giovannini-Chami (Nice, France). Late Breaking Abstract - The “one airway, one disease” concept at the light of Th2 inflammation. 4938
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
The “one airway, one disease” concept in light of Th2 inflammation
Source: Eur Respir J, 52 (4) 1800437; 10.1183/13993003.00437-2018
Year: 2018
Late Breaking Abstract - IL-33 drives influenza-induced exacerbations of asthma by halting anti-viral and Th1 responses
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017
Late Breaking Abstract - B cell adaptive immune profile in emphysema-predominant COPD
Source: International Congress 2019 – Intercellular communication in tissue remodelling of chronic lung diseases
Year: 2019
Late Breaking Abstract: A role for IL-25 as ‘initiator‘ in Th2 driven inflammation is restricted to IL-5 high Th2 patients
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010
Late Breaking Abstract - The inflammasome cluster is linked with airway NETosis in COPD
Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair
Year: 2021
Late Breaking Abstract - GATA-3 in lung CD4+T cells drives Interleukin-10 deficiency-induced lung inflammation in asthma
Source: Virtual Congress 2020 – New insights into asthma immunology: in mouse and men
Year: 2020
Modulation of inflammation by benralizumab in eosinophilic airway disease
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
Late Breaking Abstract - Formaldehyde inhalation impairs immune system and may affects severity of allergic disease
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017
Late Breaking Abstract - Hypoxia dampens the allergen-dependent adaptive immune response and ameliorates allergic asthma in vivo
Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Year: 2021
Late Breaking Abstract - Biological determinants of sputum rheology in chronic airway diseases
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020
Interleukin-33 and Th2 cytokines correlate in acute asthma
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016
Late Breaking Abstract - The impact of treatment with mepolizumab on airway remodeling in patients with severe eosinophilic asthma.
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021
Late Breaking Abstract - Hypoxia-induced responses to mimic ongoing remodelling processes in chronic lung diseases
Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Year: 2020
Late Breaking Abstract - Gender and asthma: Gender-dependent effects of obesity on allergic pulmonary inflammation
Source: International Congress 2018 – Notable Studies in Asthma
Year: 2018
Late Breaking Abstract: IL-17 inhibits IL-23 release during airway inflammation
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010
Late Breaking Abstract - Early response to benralizumab in Canadians with severe eosinophilic asthma
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021
Late Breaking Abstract - Effect of timapiprant, a DP2 antagonist, on airway inflammation in severe eosinophilic asthma
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Asthma
Year: 2019
Late Breaking Abstract - A GATA3-specific DNAzyme attenuates sputum eosinophilia in COPD patients with eosinophilic airway inflammation
Source: International Congress 2017 – Update and new perspectives in Airway Diseases
Year: 2017
Peripheral blood Th9 cells and IL-9 level in asthma patients with early and dual asthmatic response
Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept